Regenicin (OTCMKTS:RGIN) Stock Price Passes Above 50 Day Moving Average – Should You Sell?

Shares of Regenicin Inc. (OTCMKTS:RGIN – Get Free Report) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Regenicin shares last traded at $0.00, with a volume of 0 shares.

Regenicin Trading Down 100.0%

About Regenicin

(Get Free Report)

Regenicin, Inc focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc and changed its name to Regenicin, Inc in July 2010.

Further Reading

• Five stocks we like better than Regenicin
• Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
• TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
• Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
• Keysight: The AI and Defense Stock Seeing Big Price Target Boosts